Regulatory Challenges for Gene Editing Companies: Navigating Complexities
The rapid advancement of gene editing technologies, such as CRISPR and TALEN, has revolutionized the fields of medicine, agriculture, and biotechnology. However, navigating the regulatory challenges for gene editing companies remains a complex and often daunting task. As regulatory frameworks evolve globally, these companies confront significant hurdles in ensuring compliance while fostering innovation. The interplay … Read more